Cytomegalovirus Acquisition and Inflammation in Human Immunodeficiency Virus-Exposed Uninfected Zimbabwean Infants

Ceri Evans, Bernard Chasekwa, Sandra Rukobo, Margaret Govha, Kuda Mutasa, Robert Ntozini, Jean H Humphrey, Andrew J Prendergast, Ceri Evans, Bernard Chasekwa, Sandra Rukobo, Margaret Govha, Kuda Mutasa, Robert Ntozini, Jean H Humphrey, Andrew J Prendergast

Abstract

Cytomegalovirus (CMV) acquisition and inflammation were evaluated in 231 human immunodeficiency virus (HIV)-exposed uninfected (HEU) and 100 HIV-unexposed Zimbabwean infants aged 6 weeks. The HEU and HIV-unexposed infants had a similarly high prevalence of CMV (81.4% vs 74.0%, respectively; P = .14), but HEU infants had higher CMV loads (P = .005) and >2-fold higher C-reactive protein (CRP) concentrations (P < .0001). The CMV-positive HEU infants had higher CRP than the CMV-negative HEU infants; this association disappeared after adjusting for maternal HIV load. Overall, CMV acquisition is high in early life, but HEU infants have higher CMV loads and a proinflammatory milieu, which may be driven partly by maternal HIV viremia.

Keywords: HIV-exposed uninfected infants; cytomegalovirus; immune activation; inflammation; Africa.

© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
Relationship between cytomegalovirus (CMV), C-reactive protein (CRP), and human immunodeficiency virus (HIV) exposure status. A, Prevalence of CMV DNAemia at 6 weeks of age in HIV-unexposed and HIV-exposed uninfected infants. Proportions in each group compared using Fisher’s exact test. B, CMV loads in HIV-unexposed and HIV-exposed uninfected infants. Horizontal line at median. Median CMV viral loads compared between HIV-exposed and HIV-unexposed infant groups using Mann–Whitney test. Limit of quantification of CMV load: 45 copies/mL; CMV-positive samples with viral loads below the limit of quantification were arbitrarily assigned CMV load values of 40 copies/mL. C, C-reactive protein in infants with and without CMV acquisition by 6 weeks of age, stratified by HIV exposure category. White circles: CMV-negative HIV-unexposed infants; white triangles: CMV-positive HIV-unexposed infants; black squares: CMV-negative HIV-exposed uninfected infants; black diamonds: CMV-positive HIV-exposed uninfected infants. Horizontal line at median. All comparisons undertaken using Mann–Whitney tests. D, Maternal HIV disease severity in HEU infants with and without CMV acquisition by 6 weeks of age. Left y-axis: maternal HIV load; right y-axis: maternal CD4 count. Black squares: maternal viral load in CMV-negative infants; black circles: maternal viral load in CMV-positive infants; black downwards-pointing triangles: maternal CD4 count in CMV-negative infants; black upwards-pointing triangles: maternal CD4 count in CMV-positive infants. HIV-exposed uninfected infants only. Horizontal line at median. All comparisons undertaken using Mann–Whitney tests.

References

    1. Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis 2016; 16:e92–e107.
    1. Evans C, Humphrey JH, Ntozini R, Prendergast AJ. HIV-exposed uninfected infants in Zimbabwe: insights into health outcomes in the pre-antiretroviral therapy era. Front Immunol 2016; 7:190.
    1. Abu-Raya B, Smolen KK, Willems F, Kollmann TR, Marchant A. Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns. Front Immunol 2016; 7:338.
    1. Gianella S, Letendre S. Cytomegalovirus and HIV: a dangerous Pas de Deux. J Infect Dis 2016; 214Suppl 2:S67–74.
    1. Filteau S, Rowland-Jones S. Cytomegalovirus infection may contribute to the reduced immune function, growth, development, and health of HIV-exposed, uninfected African children. Front Immunol 2016; 7:257.
    1. Humphrey JH, Iliff PJ, Marinda ET, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006; 193:860–71.
    1. Malaba LC, Iliff PJ, Nathoo KJ, et al. Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe. Am J Clin Nutr 2005; 81:454–60.
    1. Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005; 19:699-708.
    1. Gumbo H, Chasekwa B, Church JA, et al. Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants. PLoS One 2014; 9:e114870.
    1. Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology 2010; 129:446–54.
    1. Reikie BA, Adams RC, Leligdowicz A, et al. Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr 2014; 66:245–55.
    1. Bunders MJ, van Hamme JL, Jansen MH, Boer K, Kootstra NA, Kuijpers TW. Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1. Sci Rep 2014; 4:6690.
    1. Puchta A, Naidoo A, Verschoor CP, et al. TNF drives monocyte dysfunction with age and results in impaired anti-pneumococcal immunity. PLoS Pathog 2016; 12:e1005368.
    1. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004; 10:119–24.
    1. Prendergast AJ, Szubert AJ, Berejena C, et al. Baseline inflammatory biomarkers identify subgroups of HIV-infected African children with differing responses to antiretroviral therapy. J Infect Dis 2016; 214:226–36.
    1. Liu AY, Lohman-Payne B, Chung MH, et al. Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya. Clin Exp Immunol 2015; 180:509–19.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir